VSEE HEALTH INC (VSEE) Stock Fundamental Analysis

NASDAQ:VSEE • US92919Y1029

0.3353 USD
-0.01 (-3.09%)
At close: Feb 24, 2026
0.337 USD
+0 (+0.51%)
After Hours: 2/24/2026, 7:52:24 PM
Fundamental Rating

1

Overall VSEE gets a fundamental rating of 1 out of 10. We evaluated VSEE against 35 industry peers in the Health Care Technology industry. VSEE may be in some trouble as it scores bad on both profitability and health. VSEE is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • VSEE had negative earnings in the past year.
  • VSEE had a negative operating cash flow in the past year.
  • In the past 5 years VSEE always reported negative net income.
  • VSEE had a negative operating cash flow in each of the past 5 years.
VSEE Yearly Net Income VS EBIT VS OCF VS FCFVSEE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

  • VSEE has a worse Return On Assets (-66.71%) than 85.71% of its industry peers.
Industry RankSector Rank
ROA -66.71%
ROE N/A
ROIC N/A
ROA(3y)-266.08%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VSEE Yearly ROA, ROE, ROICVSEE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 100K 200K 300K

1.3 Margins

  • Looking at the Gross Margin, with a value of 54.64%, VSEE is doing worse than 60.00% of the companies in the same industry.
  • VSEE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VSEE Yearly Profit, Operating, Gross MarginsVSEE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -200 -400

0

2. Health

2.1 Basic Checks

  • VSEE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, VSEE has more shares outstanding
  • The debt/assets ratio for VSEE has been reduced compared to a year ago.
VSEE Yearly Shares OutstandingVSEE Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M
VSEE Yearly Total Debt VS Total AssetsVSEE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • VSEE has an Altman-Z score of -7.35. This is a bad value and indicates that VSEE is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -7.35, VSEE is not doing good in the industry: 82.86% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.35
ROIC/WACCN/A
WACC8.41%
VSEE Yearly LT Debt VS Equity VS FCFVSEE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • A Current Ratio of 0.16 indicates that VSEE may have some problems paying its short term obligations.
  • With a Current ratio value of 0.16, VSEE is not doing good in the industry: 97.14% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.16 indicates that VSEE may have some problems paying its short term obligations.
  • VSEE has a Quick ratio of 0.16. This is amonst the worse of the industry: VSEE underperforms 97.14% of its industry peers.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.16
VSEE Yearly Current Assets VS Current LiabilitesVSEE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 77.57% over the past year.
  • Looking at the last year, VSEE shows a very strong growth in Revenue. The Revenue has grown by 121.76%.
EPS 1Y (TTM)77.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.49%
Revenue 1Y (TTM)121.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%18.67%

3.2 Future

  • Based on estimates for the next years, VSEE will show a very negative growth in Earnings Per Share. The EPS will decrease by -182.84% on average per year.
  • VSEE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 46.40% yearly.
EPS Next Y-1100%
EPS Next 2Y-182.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year64.83%
Revenue Next 2Y46.4%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

VSEE Yearly Revenue VS EstimatesVSEE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 5M 10M 15M 20M
VSEE Yearly EPS VS EstimatesVSEE Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.1 -0.2 -0.3

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for VSEE. In the last year negative earnings were reported.
  • Also next year VSEE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VSEE Price Earnings VS Forward Price EarningsVSEE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VSEE Per share dataVSEE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

  • A cheap valuation may be justified as VSEE's earnings are expected to decrease with -182.84% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-182.84%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • VSEE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

VSEE HEALTH INC

NASDAQ:VSEE (2/24/2026, 7:52:24 PM)

After market: 0.337 +0 (+0.51%)

0.3353

-0.01 (-3.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-14
Earnings (Next)N/A
Inst Owners3.36%
Inst Owner Change15.9%
Ins Owners16.1%
Ins Owner Change0%
Market Cap13.49M
Revenue(TTM)14.55M
Net Income(TTM)-12.48M
Analysts82.86
Price Target5.1 (1421.03%)
Short Float %3.45%
Short Ratio1.28
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.1%
Min Revenue beat(2)-18.49%
Max Revenue beat(2)-7.7%
Revenue beat(4)1
Avg Revenue beat(4)-8.99%
Min Revenue beat(4)-18.49%
Max Revenue beat(4)7.44%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.93
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.97
EYN/A
EPS(NY)-0.24
Fwd EYN/A
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS0.36
BVpS-0.14
TBVpS-0.49
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -66.71%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.64%
FCFM N/A
ROA(3y)-266.08%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.07%
Cap/Sales 0.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.16
Quick Ratio 0.16
Altman-Z -7.35
F-Score3
WACC8.41%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)77.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.49%
EPS Next Y-1100%
EPS Next 2Y-182.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)121.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%18.67%
Revenue Next Year64.83%
Revenue Next 2Y46.4%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-159.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year93.37%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-244.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-242.52%
OCF growth 3YN/A
OCF growth 5YN/A

VSEE HEALTH INC / VSEE FAQ

What is the fundamental rating for VSEE stock?

ChartMill assigns a fundamental rating of 1 / 10 to VSEE.


What is the valuation status of VSEE HEALTH INC (VSEE) stock?

ChartMill assigns a valuation rating of 0 / 10 to VSEE HEALTH INC (VSEE). This can be considered as Overvalued.


What is the profitability of VSEE stock?

VSEE HEALTH INC (VSEE) has a profitability rating of 0 / 10.


What is the earnings growth outlook for VSEE HEALTH INC?

The Earnings per Share (EPS) of VSEE HEALTH INC (VSEE) is expected to decline by -1100% in the next year.